“…Of note, in prostate cancer cell lines, the levels of FGF-2 and FGFR1 have been shown to increase proportionally to the degree of cancer aggressiveness and castration resistance (Nakamoto et al, 1992;Cronauer et al, 1997). The analysis of tumor specimens has shown that enhanced FGF signaling results in increased proliferation, invasiveness and resistance to therapy in several solid and hematological malignancies (Menzel et al, 1996;Konig et al, 1997;Song et al, 2000;Sezer et al, 2001;Acevedo et al, 2009;Turner et al, 2010). Moreover, hemi-or homozygous inactivation of Fgf-2 alleles in TRAMP mice with transgenic prostate adenocarcinoma resulted in increased survival by inhibiting progression toward a poorly differentiated and highly metastatic phenotype (Polnaszek et al, 2003).…”